Cost Guide · Updated November 2026

GLP-1 Cash Pay vs Insurance: Which Path Makes Sense in 2026?

Brand-name GLP-1 list prices run as high as $1,349.02 a month for Wegovy, but almost nobody without coverage pays list anymore. As of Nov 4, 2026, Novo Nordisk and Eli Lilly sell their brands directly for $149 to $499 a month at most doses. Compounded versions cost a similar amount but are not FDA-approved, and the FDA has moved to restrict them. Insurance can bring brand-name costs lower still, but approval takes time and many plans exclude weight-loss drugs. After researching providers and paying cash for tirzepatide myself, here is how I think about this decision.

I spent three months fighting my insurance company before switching to cash pay through a telehealth provider. During those three months, I filled out forms, called the prior authorization department twice, got denied, filed an appeal, and waited. Meanwhile, my weight kept climbing. When I finally gave up and paid out of pocket, I had my prescription within a week. That experience shaped how I view this tradeoff, and I have since talked to dozens of people who went through similar frustrations.

This guide breaks down both paths with real numbers so you can make the right call for your situation.

The Real Cost Breakdown in 2026

Before comparing the paths, you need to understand what GLP-1 medications actually cost at every level.

Brand-Name with Insurance

If your insurance covers GLP-1 medications (and that is a big “if”), your cost depends on your plan’s tier, copay or coinsurance, and deductible. With commercial coverage, maker savings cards can cut the copay further. For example, the Ozempic savings card lets eligible patients pay as little as $25 a month, with savings capped at $100 a month. Savings cards exclude people on government insurance such as Medicare and Medicaid.

The catch: many employer plans do not cover GLP-1s for weight loss, while coverage for type 2 diabetes is much broader. If your primary diagnosis is obesity, check your formulary before assuming anything. Our insurance coverage guide breaks down which insurers cover what.

Brand-Name Without Insurance

List prices are high, but both makers now sell directly to self-paying patients at much lower prices. These are the self-pay prices on the makers’ own pages as of Nov 4, 2026:

Novo also offers new patients $199 a month for the first two fills of the lowest Ozempic and Wegovy doses through December 31, 2026. Zepbound’s $449 price for 7.5mg and up applies only if you refill within 45 days. Otherwise it is $499 to $699. The Wegovy list price is $1,349.02 per package, and Novo has announced a $675 list price for Wegovy and Ozempic starting January 1, 2027.

Self-pay purchases are made outside your insurance, so they usually do not count toward your deductible or out-of-pocket maximum. Terms change often, so check the maker page before you order.

Compounded Cash Pay Through Telehealth

Many telehealth providers sell compounded semaglutide and compounded tirzepatide, often with a membership fee. Prices vary by provider and dose, and we did not re-verify each provider’s price for this guide. Check our provider directory for dated prices.

The rules have changed. The FDA declared the semaglutide and tirzepatide shortages over and ended the grace periods for mass compounding of copies. In February 2026 the FDA said it intends to restrict GLP-1 ingredients used in non-approved compounded drugs and to act against misleading marketing. The FDA does not review compounded drugs for safety, effectiveness, or quality and has received reports of hospitalizations linked to dosing errors.

I pay around $299 per month for compounded tirzepatide through my telehealth provider, all-in. That is my own cost, not a quote you can count on. No insurance involvement. No prior auth. The medication arrives at my door. For the full breakdown of provider pricing, see our cheapest GLP-1 online guide or browse the provider directory.

The Insurance Fight: What It Actually Takes

If you decide to go the insurance route, here is what the process typically looks like. I want to be honest about the timeline and effort involved, because most people underestimate both.

Step 1: Confirm Coverage

Call your insurance company and ask specifically whether GLP-1 medications are covered for weight management (not just diabetes). Ask for the formulary tier and any prior authorization requirements. Get the answers in writing if possible.

Step 2: Prior Authorization

Most insurers require prior authorization for GLP-1s used for weight loss. Your doctor submits paperwork proving you meet the criteria. Common requirements include:

• BMI of 30+ (or 27+ with at least one weight-related comorbidity like hypertension, type 2 diabetes, or sleep apnea)
• Documentation of failed diet and exercise attempts (usually 3 to 6 months of records)
• Step therapy: Some plans require you to try another weight loss medication or program first
• Lab work: Recent bloodwork showing relevant markers

Prior authorization decisions can take days to weeks depending on the plan.

Step 3: Denial (Common)

Prior authorization denials for GLP-1 weight loss medications are common. We could not find a reliable public source for a national denial rate. Common denial reasons include:

• Patient does not meet BMI threshold
• Insufficient documentation of prior weight loss attempts
• Step therapy not completed
• Medication classified as “not medically necessary” for the stated diagnosis
• Plan simply excludes weight management drugs

Step 4: Appeal

If denied, you have the right to appeal, and then to an external review in many cases. Your doctor writes a letter of medical necessity explaining why this specific medication is needed. Appeals add weeks. Some patients go through two rounds before getting approved.

Total Timeline

From first phone call to filled prescription, the insurance route can take anywhere from a couple of weeks (approved on the first try) to several months (denials and appeals). If your plan categorically excludes weight management drugs, appeals usually will not work.

That can be weeks of your life spent on paperwork, phone calls, and waiting. For someone who is ready to start treatment now, that delay has a real cost beyond just the hours spent.

Cash Pay: The Advantages

After going through the insurance process myself and eventually switching to cash, here is what I gained.

Start treatment quickly. Telehealth providers and the maker self-pay programs can often get you a prescription within days. No prior auth, no waiting for approval letters, no back-and-forth between your doctor’s office and the insurance company. You fill out a health questionnaire, do a video or async consultation, and the medication ships.

No prior authorization hoops. You do not need to prove you tried and failed other treatments first. A licensed clinician still decides whether the drug is right for you, usually using the label criteria (obesity, or overweight with a weight-related condition).

Privacy. Cash pay means your GLP-1 use does not appear on your health insurance claims. It can still show up in pharmacy records and your medical chart, and life or disability insurance applications may ask about medications directly. Answer those questions honestly.

Predictable monthly cost. You know exactly what you pay every month. No surprise bills from deductible resets in January. No formulary changes mid-year that suddenly make your medication Tier 4 instead of Tier 2.

Simpler provider switching. If your telehealth provider raises prices or you find a better option, you can switch without worrying about network restrictions. Our provider comparison pages make it easy to compare costs across dozens of options.

Cash Pay: The Disadvantages

Cash pay is not all upside. Here is what you give up.

Higher total out-of-pocket spend. If your insurance would cover a GLP-1 with a $50 copay and you pay $349 cash instead, you spend about $3,600 more over 12 months. That is real money.

Compounded vs. brand quality questions. Many cash-pay telehealth providers prescribe compounded medications, not brand-name. Compounded semaglutide and tirzepatide are made by compounding pharmacies, not Novo Nordisk or Eli Lilly. The FDA does not review them for safety, effectiveness, or quality, and says some pharmacies have used salt forms such as semaglutide sodium, which are different active ingredients. Purity, potency, and sterility depend on the specific pharmacy. Brand self-pay programs now cost about the same, which removes much of the price case for compounding. Our guide on compounded vs. brand GLP-1s covers this in detail.

No coverage for complications. If you experience a side effect that requires medical attention, insurance handles that separately from the medication cost. But if you are fully outside the insurance system for your GLP-1 treatment, your primary care provider may not have full context on your dosing and medication history. Keep your doctor informed regardless of how you pay.

Not tax-deductible for everyone. The IRS lets you count weight-loss costs as medical expenses when they treat a specific disease diagnosed by a physician, such as obesity, and prescription drugs qualify. You can only deduct the part of your medical costs above 7.5% of your adjusted gross income, and only if you itemize. Check with a tax advisor.

Ongoing expense with no ceiling. Insurance has out-of-pocket maximums. Cash pay does not. If you are on a GLP-1 for two or three years (and many people will be, since these medications work best with continued use), the cumulative cost at $300 per month is $7,200 to $10,800.

Side-by-Side Comparison

The Decision Framework: When Each Path Makes Sense

After talking to dozens of people in both camps, here is how I think about the decision.

Insurance makes sense when:

1. Your plan explicitly covers GLP-1s for weight management. Call and confirm before investing time. If your plan covers it at Tier 2 or 3, the math is strongly in favor of insurance.
2. You have already met your deductible. Later in the year, after other medical expenses, your out-of-pocket for a GLP-1 may be minimal.
3. You are not in a rush. If you can wait 4 to 8 weeks for the prior auth process to play out, and you have the patience for potential appeals, the long-term savings are worth it.
4. You have a diagnosis your plan covers. Type 2 diabetes is covered far more often than obesity alone. Some plans also cover Zepbound for obstructive sleep apnea or Wegovy for heart disease risk reduction.
5. Your copay is lower than the self-pay price. If your plan covers the drug, insurance is usually the cheapest way to get brand-name medication.

Cash pay makes sense when:

1. Your insurance does not cover weight management drugs. No amount of prior auth will fix a categorical exclusion. Check your plan documents first.
2. You need to start now. If your health situation is urgent or you are simply done waiting, cash pay eliminates weeks of delay.
3. You have been denied and do not want to appeal. The appeal process is draining. If you have already been through one denial and the thought of more paperwork makes you want to quit entirely, just pay cash and start.
4. You value simplicity and control. Some people (myself included) prefer knowing exactly what they pay, choosing their provider freely, and keeping the process clean.
5. You can afford $150 to $500 per month. This only works if the cost does not create financial stress. GLP-1 treatment usually lasts a year or more. Budget accordingly.

The hybrid approach

Some people start with a brand self-pay program to begin treatment quickly, then work the insurance process in the background. If insurance eventually approves, they switch to filling through their pharmacy. Any change of product or dose should go through your prescriber. This gives you the best of both paths, though it requires managing two processes simultaneously.

How to Reduce Cash Pay Costs

If you go the cash route, here are concrete ways to pay less.

Compare multiple options. Pricing varies across telehealth providers for the same medication, and the maker self-pay prices are a useful benchmark. Our provider directory lists prices with the date we checked them.

Watch for introductory pricing. Many providers offer lower rates for the first month or first three months. Factor in what the price becomes after the intro period ends.

Ask about multi-month plans. Some providers offer discounts for committing to several months upfront. Check the refund terms first.

Use an HSA or FSA. Prescription GLP-1s used to treat a diagnosed condition such as obesity are generally eligible expenses. Paying with pre-tax money saves you roughly your tax rate. LillyDirect lists its self-pay medicines as FSA/HSA eligible, with eligibility varying by plan.

Check manufacturer self-pay programs. LillyDirect (Zepbound, Mounjaro, Foundayo) and NovoCare (Wegovy, Ozempic) sell directly to self-paying patients, and prices have dropped several times. Check them before you renew anything.

My Personal Take

I chose cash pay and I would make the same choice again. The three months I spent fighting insurance were three months I was not on medication, not losing weight, and not improving my health markers. At $299 per month, my compounded tirzepatide costs me about $3,600 per year. That is a lot of money. But the alternative was continuing to gain weight while waiting for a bureaucracy to decide my treatment was “medically necessary.”

If I had known upfront that my insurance would deny me, I would have skipped the insurance attempt entirely and started cash pay from day one. That is the key insight: figure out your insurance situation before you need the medication, not after. Call your insurer, check your formulary, and understand your prior auth requirements now. If the answer looks bad, compare the maker self-pay prices with your other options and talk to your prescriber.

For more on finding affordable GLP-1 treatment, see our cheapest GLP-1 online guide. If you are comparing specific providers, the provider directory has dated pricing and medication options.

FAQ

Is compounded semaglutide the same as brand-name Ozempic?

No. Brand-name Ozempic and Wegovy are FDA-approved. Compounded semaglutide is not, and the FDA does not review it for safety, effectiveness, or quality. Some compounders have used salt forms such as semaglutide sodium, which the FDA says are different active ingredients. The FDA also bars marketing that claims compounded drugs are the same as approved drugs.

How long does GLP-1 prior authorization take?

It varies by plan. Initial decisions can take days to weeks, and each appeal adds more weeks. With multiple denials and appeals, the process can stretch to several months. Denials are common for weight-management requests.

Can I switch from cash pay to insurance later?

Yes. If your insurance situation changes or you get approved through prior authorization, you can switch to filling your prescription through a traditional pharmacy with insurance coverage. You will need a new prescription from an in-network provider in most cases, since telehealth prescriptions from cash-pay providers may not transfer directly. Talk to your insurance company about their specific process.

Does paying cash for GLP-1s affect my insurance rates?

Cash-pay fills are not submitted as health insurance claims, so they do not appear in your plan’s claims history. They can still appear in pharmacy and medical records, and life or disability insurance applications may ask about medications directly.

Are GLP-1 medications tax deductible if I pay cash?

They can. The IRS counts weight-loss costs as medical expenses when they treat a specific disease diagnosed by a physician, such as obesity. If you itemize, medical expenses above 7.5% of your adjusted gross income are deductible. HSA and FSA funds can generally be used for them too. Consult a tax advisor for your specific situation.

Related

Guides:

• Cheapest GLP-1 Online · Insurance Coverage · Medicare Coverage
• Compounded vs Brand GLP-1 · Side Effects · Mounjaro Dosage Guide
• Oral vs Injectable · Exercise and Muscle

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Compare: All Providers · Best GLP-1 Programs · All Guides

What we checked

This AI-assisted public-source desk check reviewed the self-pay pages for Wegovy (NovoCare), Ozempic, and LillyDirect (Zepbound, Mounjaro, Foundayo), Novo Nordisk’s list price announcement, FDA statements on compounded GLP-1 drugs, and IRS Publication 502 on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.